Intravenous Neonatal Central Access Safety Trial
Recruiting
N/A
Interventional Study
Newborn Complication
Catheter Complications
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 1 Hour – 3 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 736 (estimated)
- Sponsor
- University of Turin, Italy · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU).
In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated.
In-line filters in the intravenous administr…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients admitted to NICU with at least one central venous catheter
Exclusion Criteria:
* Patients with peripheral venous catheter, patients with inflammatory episode at the time of enrollment
Contacts